Nidzica, Poland

Anna Skwarska

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Gdansk University of Technology. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anna Skwarska. Retrieved from https://idiyas.com/inventor/anna-skwarska

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Anna Skwarska: Innovator in Antitumor Pharmaceuticals

Introduction

Anna Skwarska is a notable inventor based in Nidzica, Poland. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with antitumor activity. Her innovative work has the potential to impact cancer treatment and prevention.

Latest Patents

Anna Skwarska holds a patent for "Asymmetric bis-acridines with antitumour activity and their uses." This patent discloses novel asymmetric bis-acridines that exhibit antitumor properties. These compounds are particularly useful in pharmaceuticals for the treatment or prevention of neoplasms.

Career Highlights

Throughout her career, Anna has been associated with esteemed institutions such as Gdansk University of Technology and Politechnika Gdanska. Her work in these organizations has allowed her to advance her research and contribute to the scientific community.

Collaborations

Anna has collaborated with notable colleagues, including Jerzy Kazimierz Konopa and Barbara Horowska. These partnerships have enriched her research and fostered innovation in her field.

Conclusion

Anna Skwarska's contributions to antitumor pharmaceuticals highlight her role as an influential inventor. Her work continues to pave the way for advancements in cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…